Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery

Advances in Therapy

Volumn 26, Issue 4, 2009, Pages 462-468

  Wang, Hongmei ^a   Gong, Ming ^a   Zhou, Bin ^a   Dai, Anlu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; Inhaled milrinone; Mitral valve surgery; Pulmonary hypertension; Pulmonary vascular resistance

Indexed keywords

FENTANYL; MILRINONE; PROPOFOL;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG TOLERABILITY; FEMALE; HEART INDEX; HEART VALVE SURGERY; HEMODYNAMICS; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MITRAL VALVE; POSTOPERATIVE CARE; PULMONARY HYPERTENSION; PULMONARY SHUNT; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ADMINISTRATION, INHALATION; ADULT; ANALYSIS OF VARIANCE; CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; MITRAL VALVE; POSTOPERATIVE CARE; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 73449126557     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0019-4     Document Type: Article

References (17)

1. F. Roques S.A. Nashef P. Michel 1999 Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients Eur J Cardiothorac Surg 15 816 822 10431864 10.1016/S1010-7940(99) 00106-2 1:STN:280:DyaK1MzlvVyisw%3D%3D (Pubitemid 29331957)
2. K. Bando M.W. Turrentine T.G. Sharp 1996 Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management J Thorac Cardiovasc Surg 112 1600 1607 8975852 10.1016/S0022-5223(96)70019-3 1:STN:280:DyaK2s7ivF2ktA%3D%3D (Pubitemid 26425733)
3. B. Riedel 1999 The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery Int Anesthesiol Clin 37 55 79 10347835 10.1097/00004311-199903720-00005 1:STN:280:DyaK1M3nslWrsQ%3D%3D
4. R. Voswinckel F. Reichenberger B. Enke 2008 Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension Pulm Pharmacol Ther 21 824 832 18657627 10.1016/j.pupt.2008.07.003 1:CAS:528:DC%2BD1cXhtV2jtb7K
5. O.V. Evgenov D.S. Kohane K.D. Bloch 2007 Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation Am J Respir Crit Care Med 176 1138 1145 17872487 10.1164/rccm.200707-1121OC 1:CAS:528: DC%2BD1cXhvFSnuw%3D%3D (Pubitemid 350223760)
6. J.H. Levy J.M. Bailey G.M. Deeb 2002 Intravenous milrinone in cardiac surgery Ann Thorac Surg 73 325 330 11834047 10.1016/S0003-4975(01)02719-9 (Pubitemid 34084602)
7. N. Galiè A. Torbicki R. Barst 2004 Guidelines on diagnosis and treatment of pulmonary arterial hypertension The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 25 2243 2278
8. I. Schulze-Neick P. Hartenstein J. Li 2003 Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease Circulation 108 suppl.1 II167 II173 12970227
9. B.D. Foltz E.A. Hessel 2nd T.D. Ivey 1984 The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest J Thorac Cardiovasc Surg 88 238 247 6748718 1:STN:280:DyaL2c3mvFWltw%3D%3D
10. F. Guarracino C. Cariello A. Danella 2005 Right ventricular failure: physiology and assessment Minerva Anestesiol 71 307 312 15886593 1:STN:280:DC%2BD2M3kslCquw%3D%3D
11. P. Andrivet J. Cadranel B. Housset R. Herigault A. Harf S. Adnot 1993 Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency Effects of indomethacin. Chest. 103 500 507 1:STN:280:DyaK3s7mtFOmsA%3D%3D
12. M.M. Hoeper H.J. Seyfarth G. Hoeffken 2007 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Eur Respir J 30 1096 1102 17652314 10.1183/09031936.00032407 1:CAS:528:DC%2BD1cXjs1WhtA%3D%3D (Pubitemid 351194755)
13. A. Haraldsson N. Kieler-Jensen S.E. Ricksten 2001 The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension Anesth Analg 93 1439 1445 10.1097/00000539-200112000-00018 1:CAS:528:DC%2BD38Xhs1Khtg%3D%3D
14. Y. Lamarche L.P. Perrault S. Maltais K. Tetreault J. Lambert A.Y. Denault 2007 Preliminary experience with inhaled milrinone in cardiac surgery Eur J Cardiothorac Surg 31 1081 1087 17400468 10.1016/j.ejcts.2007.02.019 (Pubitemid 46729654)
15. A. Sablotzki W. Starzmann R. Scheubel S. Grond E.G. Czeslick 2005 Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates Can J Anaesth 52 1076 1082 16326679 10.1007/BF03021608
16. R. Rossaint K.J. Falke F. López K. Slama U. Pison W.M. Zapol 1993 Inhaled nitric oxide for the adult respiratory distress syndrome N Engl J Med 328 399 405 8357359 10.1056/NEJM199302113280605 1:STN:280:DyaK3s7jtlagsA%3D%3D (Pubitemid 23042288)
17. R. Dhand 2007 Inhalation therapy in invasive and noninvasive mechanical ventilation Curr Opin Crit Care 13 27 38 17198046 10.1097/MCC.0b013e328012e022 (Pubitemid 46061279)